Digitala Vetenskapliga Arkivet

Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
A clinician’s experience of using the Cardiac Reader NT-proBNP point-of-care assay in a clinical setting
Linköping University, Department of Medicine and Health Sciences, Cardiology . Linköping University, Faculty of Health Sciences. Östergötlands Läns Landsting, Heart Centre, Department of Cardiology.
Linköping University, Department of Medicine and Health Sciences, Cardiology . Linköping University, Faculty of Health Sciences. Östergötlands Läns Landsting, Heart Centre, Department of Cardiology.ORCID iD: 0000-0002-9375-5087
2008 (English)In: European Journal of Heart Failure, ISSN 1388-9842, E-ISSN 1879-0844, Vol. 10, no 3, p. 260-266Article in journal (Refereed) Published
Abstract [en]

The evaluation of natriuretic peptides has become increasingly valuable in a clinical setting, where information is often needed promptly.

Objectives: To compare the usefulness of the recently released Roche Cardiac Reader ® NT-proBNP assay against the Roche Elecsys® NT-proBNP laboratory system in a clinical setting.

Design and Results: Blood samples from 440 patients admitted for acute coronary syndromes, worsening of heart failure, or as policlinic heart failure patients were evaluated. The relation between the assays was analysed and the diagnostic concordance calculated. A good correlation was found between the assays (r=0.96, 95% CI: 0.94-0.97) with a diagnostic concordance of 0.93. A separate analysis was performed in the range where most clinical decisions are made (60-3000 ng/L), with a diagnostic concordance of 88%. The usefulness in a clinical setting where time is important was high.

Conclusion: The Roche Cardiac Reader® NT-proBNP assay has been evaluated in a clinical setting. The point-of-care method shows good results, although with a restricted analytical range compared with the reference.

Place, publisher, year, edition, pages
Institutionen för medicin och hälsa , 2008. Vol. 10, no 3, p. 260-266
Keywords [en]
Heart failure, Natriuretic peptides, Point-of-care
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-11488DOI: 10.1016/j.ejheart.2008.01.005OAI: oai:DiVA.org:liu-11488DiVA, id: diva2:17914
Note
Original publication: Alehagen U, and Janzon M, A clinician’s experience of using the Cardiac Reader NT-proBNP point-of-care assay in a clinical setting, 2008, European Journal of Heart Failure, (10), 3, 260-266. http://dx.doi.org/10.1016/j.ejheart.2008.01.005. Copyright: Elsevier B.V., http://www.elsevier.com/Available from: 2008-04-11 Created: 2008-04-11 Last updated: 2017-12-13

Open Access in DiVA

fulltext(157 kB)3225 downloads
File information
File name FULLTEXT01.pdfFile size 157 kBChecksum SHA-1
877b9b88884e92673c5a286311600dc3d5768c1262c3181a65123231c0de2d577d321c88
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Search in DiVA

By author/editor
Alehagen, UrbanJanzon, Magnus
By organisation
Cardiology Faculty of Health SciencesDepartment of Cardiology
In the same journal
European Journal of Heart Failure
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 3226 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 735 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf